Establish the long-term safety and efficacy of pegcetacoplan in participants with C3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN)
An Open-Label, nonrandomized, extension study to evaluate long-term safety and efficacy of pegcetacoplan in patients with C3G or IC-MPGN
Completion of APL310 Study, willing to comply with birth control requirements.
Principal Investigator